Synvista Therapeutics Inc SYNI Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Oct 16
Last close · Previous close $0.00
- 52-week change
- unchangedPrice only
- Distributions
- $0.00Per share, last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.00unchangedFri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Oct 15
- Volume0.00Oct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.00Last 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.00 to $0.00; now $0.00
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
SYNI trailed the S&P 500 in all 7 periods.
| Period | SYNI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SYNI: unchanged S&P 500: up 1.5% | SYNI trailed the S&P 500 by 1.5 percentage points Trailed |
| 3M | SYNI: unchanged S&P 500: up 1.9% | SYNI trailed the S&P 500 by 1.9 percentage points Trailed |
| YTD | SYNI: unchanged S&P 500: up 12.8% | SYNI trailed the S&P 500 by 12.8 percentage points Trailed |
| 1Y | SYNI: unchanged S&P 500: up 16.8% | SYNI trailed the S&P 500 by 16.8 percentage points Trailed |
| Long term | ||
| 3Y | SYNI: down 99.0% S&P 500: up 81.5% −78.5% vs +22.0% a year | SYNI trailed the S&P 500 by 180.5 percentage points Trailed |
| 5Y | SYNI: down 99.0% S&P 500: up 83.1% −60.2% vs +12.9% a year | SYNI trailed the S&P 500 by 182.1 percentage points Trailed |
| 10Y | SYNI: down 99.9% S&P 500: up 319.6% −49.9% vs +15.4% a year | SYNI trailed the S&P 500 by 419.5 percentage points Trailed |
$10,000 invested in SYNI 10 years ago (Oct 14, 2016) would be worth about $10 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,964.
SYNI trailed the S&P 500 in all 7 periods.
| Period | SYNI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SYNI: unchanged S&P 500: up 1.2% | SYNI trailed the S&P 500 by 1.2 percentage points Trailed |
| 3M | SYNI: unchanged S&P 500: up 1.7% | SYNI trailed the S&P 500 by 1.7 percentage points Trailed |
| YTD | SYNI: unchanged S&P 500: up 11.9% | SYNI trailed the S&P 500 by 11.9 percentage points Trailed |
| 1Y | SYNI: unchanged S&P 500: up 15.5% | SYNI trailed the S&P 500 by 15.5 percentage points Trailed |
| Long term | ||
| 3Y | SYNI: down 99.0% S&P 500: up 75.0% −78.5% vs +20.5% a year | SYNI trailed the S&P 500 by 174.0 percentage points Trailed |
| 5Y | SYNI: down 99.0% S&P 500: up 71.2% −60.2% vs +11.4% a year | SYNI trailed the S&P 500 by 170.2 percentage points Trailed |
| 10Y | SYNI: down 99.9% S&P 500: up 258.1% −49.9% vs +13.6% a year | SYNI trailed the S&P 500 by 358.0 percentage points Trailed |
$10,000 invested in SYNI 10 years ago (Oct 14, 2016) would be worth about $10 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,813.
All-time high
$22.65
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Oct 31, 1994.
Stock splits
SYNI hasn’t split since its price history begins in 1994.
About Synvista Therapeutics Inc
Synvista Therapeutics, Inc. (Synvista), formerly Alteon, Inc., is a product-based biotechnology company engaged in the development of diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease. The Company's lead drug candidate, alagebrium chloride or alagebrium, is an advanced glycation end-product crosslink breaker being developed for diastolic heart failure (DHF). Synvista is also managing a discovery and development program to produce small molecule drugs that mimic the enzyme glutathione peroxidase (GPx). One of the Company's GPx mimetics, ALT-2074, is in Phase II clinical trials.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New Jersey, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
SYNI news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
SYNI stock FAQ
What is SYNI stock’s price today?
Synvista Therapeutics (SYNI) traded at $0.00 at the close on , unchanged from the previous close of $0.00. Over the past 52 weeks it has traded between $0.00 and $0.00.
If you invested $1,000 in SYNI 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in SYNI on would be worth about $1 at the close on , a total return of −99.9%. The same $1,000 would be worth $10 if invested five years ago, $1,000 if invested one year ago, $0 if invested 20 years ago, and $0 if invested 30 years ago. Past performance doesn’t predict future returns.
What is Synvista Therapeutics’s market cap?
Synvista Therapeutics’s market capitalization is about $0.0 thousand. That’s Tiingo’s daily market cap for , at that day’s closing price of $0.00 (how market cap works).
Does SYNI pay a dividend?
Synvista Therapeutics hasn’t paid a dividend in the last twelve months.
What is SYNI’s 52-week high and low?
Over the past 52 weeks SYNI has traded as low as $0.00 and as high as $0.00. At $0.00 at the close on , it is 0.0% below that high and 0.0% above the low.
What is SYNI’s all-time high?
SYNI’s highest closing price was $22.65 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.
Has SYNI stock ever split?
No. SYNI hasn’t split since its price history begins in 1994.
How has SYNI stock performed?
Including dividends and measured to the close on , SYNI has returned 0.0% so far this year and 0.0% over the past year, and −99.0% over five years (−60.2% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What sector and industry is Synvista Therapeutics in?
Synvista Therapeutics is in the Healthcare sector and the Biotechnology industry, and is headquartered in New Jersey, USA.
What exchange does SYNI trade on?
Synvista Therapeutics trades on the PINK under the ticker symbol SYNI. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.